Are RSV contact or droplet precautions needed? Both. RSV spreads mainly by large respiratory droplets and contaminated surfaces, so the standard of care is contact plus droplet precautions—gown and gloves at the door, a surgical mask within about 3 feet, and eye protection for aerosol-generating care. Current CDC guidance (2024 update) frames this as standard plus contact plus droplet precautions for the duration of illness in hospitalized infants and adults. Neither route alone explains transmission because RSV survives hours on hard surfaces and infects efficiently through the eyes and nose after hand contact.
How RSV Actually Gets From One Person to Another
RSV is an enveloped RNA virus with a lipid membrane, which sounds fragile but behaves stubbornly on hard surfaces. The virus loses infectivity fastest on porous materials like tissue or cloth and persists longest on non-porous plastic and stainless steel, where viable virus can remain detectable for up to 6 hours under experimental conditions. That persistence is the mechanistic reason contact precautions are not optional.
Transmission happens through three overlapping routes. Large droplets (over 5 microns) launch from coughing, sneezing, and crying and travel roughly 3 feet before gravity pulls them down. Direct and indirect contact transfers virus from a doorknob, toy, or bedding to a hand, then to a mucous membrane. Aerosolized fine particles (under 5 microns) form a smaller but real third route, mainly during procedures like intubation or high-flow oxygen.
The eye is the underappreciated portal. RSV infects through the conjunctiva as readily as the nasal mucosa, which is why eye protection earns a place in precaution bundles even though it is often dropped in practice. In plain terms: the virus does not need to reach your lungs directly; it just needs to reach your face, and your hands carry it there.
Incubation runs 4 to 6 days, and viral shedding in infants can persist for 1 to 3 weeks, longer in immunocompromised patients and premature infants. That shedding tail is why "precautions until symptoms resolve" and "precautions until discharge" are not the same instruction.
Quantifying Each Route: The Numbers Behind the Bundles
Droplet precautions alone leave a measurable gap. A frequently cited modeling and observational comparison found that contact-only strategies reduce nosocomial RSV transmission by roughly 50 to 70 percent, while adding droplet precautions pushes the reduction higher because it intercepts the dominant large-droplet spray that surface cleaning cannot touch.
| Route | Particle size | Typical range | Dominant setting | Best countermeasure | Residual risk if missed |
|---|---|---|---|---|---|
| Contact (fomite/hand) | N/A | Surface to face | Toys, bedding, shared equipment | Gown, gloves, hand hygiene | High in pediatric wards |
| Droplet | Over 5 microns | About 3 feet | Coughing, crying infants | Surgical mask, spatial separation | High during close care |
| Aerosol | Under 5 microns | Room-scale | Intubation, suctioning, high-flow O2 | N95 or higher, airborne isolation | Low but nonzero |
| Direct splash | Variable | Under 1 foot | Suctioning, coughing in face | Eye protection, face shield | Moderate |
The mask threshold matters. A surgical mask filters large droplets effectively at close range but does not seal, so it does not substitute for an N95 during aerosol-generating procedures. That distinction is where many hospitals get the bundle wrong: they apply droplet precautions universally and then skip the upgrade when a nebulizer or open suction enters the room.
Hand hygiene compliance is the quiet variable. Observed compliance in busy pediatric units commonly runs 40 to 60 percent, meaning even a perfectly designed precaution bundle underperforms if the entry-point behavior fails. The bundle is only as strong as its weakest measured step.
Precautions by Setting: Hospitals, Homes, and Long-Term Care
Hospitalized infants under 12 months warrant the full contact-plus-droplet bundle, and most guidance extends it for the duration of illness rather than a fixed day count. For adults, particularly those over 65 or with COPD or heart failure, the same bundle applies because shedding patterns differ and complications rise sharply with age.
Home settings do not require gowns, but the logic scales down. A caregiver can reduce household transmission substantially by handwashing before and after infant contact, avoiding shared towels, and keeping symptomatic siblings physically separated. RSV attack rates within households are high—commonly 40 to 60 percent when a young infant is the index case—so household measures are not trivial.
Long-term care facilities present the hardest case. Older adults shed less virus but suffer higher mortality, and shared dining and activity spaces defeat distance-based droplet control. Contact plus droplet precautions with cohorting of symptomatic residents is the practical standard, and staff movement between rooms is the main leakage point.
A common misconception is that RSV is "just a cold" and needs no isolation. That framing drives underuse of precautions in adult wards, where the actual burden sits. RSV causes an estimated 60,000 to 160,000 hospitalizations annually among US adults over 65, and mortality in that group rivals some influenza seasons. Another misconception: gloves replace hand hygiene. They do not; contamination of gloves is common and glove removal is a frequent self-contamination event.
Timeline: When Precautions Start and When They Stop
| Phase | Timing | Precaution status | Key action |
|---|---|---|---|
| Exposure / incubation | Day 0 to 4-6 | Not yet symptomatic, no isolation | Watch for symptoms; hand hygiene |
| Symptom onset | Day 4-6 typical | Full contact plus droplet initiated | Gown, gloves, mask, eye protection |
| Peak shedding | Days 1 to 8 | Full bundle maintained | Limit transport, dedicated equipment |
| Improving phase | Days 8 to 14 | Bundle continues until symptoms resolve | Reassess daily, not by calendar |
| Extended shedding | Up to 3 weeks (infants, immunocompromised) | Precautions often extended | Individualized duration decision |
| Post-discharge / home | After discharge | No formal isolation but household measures | Hand hygiene, separation of symptomatic |
The reconciliation point: the 3-foot droplet radius, the 6-hour surface viability, and the 4-to-6-day incubation describe different things—distance, durability, and delay—so none contradicts the others. The "until symptoms resolve" rule and the "up to 3 weeks shedding" figure also coexist because shedding outlasts visible illness in a minority of patients, and precautions are titrated to risk rather than to a single clock.
What to Actually Do: A Step-by-Step Precaution Checklist
The practical answer is a bundle, not a single choice. Apply it in this order and the failure points become obvious.
- Screen at entry: ask about cough, fever, and known RSV exposure before a patient enters a shared space.
- Don gown and gloves before room entry; remove them before leaving and perform hand hygiene immediately.
- Wear a surgical mask within 3 feet for routine care; upgrade to an N95 for intubation, open suction, or high-flow oxygen.
- Add eye protection for any procedure likely to generate splashes or forceful coughing.
- Dedicate equipment (stethoscope, thermometer, toys) to the patient room and clean high-touch surfaces at least twice daily.
- Continue precautions until symptoms resolve, and reassess duration daily rather than by a fixed day count.
Red-flag warnings for escalation:
- A hospitalized infant with worsening respiratory distress, apnea, or feeding refusal needs immediate reassessment, not just stricter isolation.
- An adult over 65 with new hypoxia or confusion warrants urgent evaluation for RSV complications.
- Any aerosol-generating procedure in a suspected case without N95 protection is a breach to report.
- Staff with symptoms should be excluded from caring for high-risk infants.
Limitations and What the Evidence Does Not Settle
The precise contribution of the aerosol route for RSV remains debated. Observational data cannot cleanly separate droplet from aerosol transmission in real wards, so the current guidance is a pragmatic bundle rather than a route-specific prescription. Studies using PCR detection also overstate viable virus, since genetic material can persist long after infectivity is gone.
Precaution duration is another open question. There is no single validated day threshold that fits every patient; immunocompromised hosts and premature infants can shed for weeks, and blanket rules either over-isolate or under-protect them. Guideline bodies—notably CDC's 2024 update and WHO infection-control guidance—converge on symptom-based duration with clinical judgment, which is honest but leaves room for inconsistency between institutions.
The biggest practical gap is compliance, not knowledge. The evidence is clear that contact plus droplet precautions reduce transmission; the failure is in hand hygiene and equipment dedication at the point of care. A reader who takes one thing from this page should take that: the answer to whether RSV needs contact or droplet precautions is both, and the bundle only works if every link holds.